4.7 Review

Efficacy of Commercial Weight-Loss Programs An Updated Systematic Review

期刊

ANNALS OF INTERNAL MEDICINE
卷 162, 期 7, 页码 501-+

出版社

AMER COLL PHYSICIANS
DOI: 10.7326/M14-2238

关键词

-

资金

  1. career development award from the National Heart, Lung, and Blood Institute [K23HL116601, 1K01HL096409]
  2. Johns Hopkins medical student summer research program
  3. medical student research program in diabetes at JHU-UMD Diabetes Research Center (National Institute of Diabetes and Digestive and Kidney Diseases) [P30DK079637]

向作者/读者索取更多资源

Background: Commercial and proprietary weight-loss programs are popular obesity treatment options, but their efficacy is unclear. Purpose: To compare weight loss, adherence, and harms of commercial or proprietary weight-loss programs versus control/education (no intervention, printed materials only, health education curriculum, or <3 sessions with a provider) or behavioral counseling among overweight and obese adults. Data Sources: MEDLINE and the Cochrane Database of Systematic Reviews from inception to November 2014; references identified by program staff. Study Selection: Randomized, controlled trials (RCTs) of at least 12 weeks' duration; prospective case series of at least 12 months' duration (harms only). Data Extraction: Two reviewers extracted information on study design, population characteristics, interventions, and mean percentage of weight change and assessed risk of bias. Data Synthesis: We included 45 studies, 39 of which were RCTs. At 12 months, Weight Watchers participants achieved at least 2.6% greater weight loss than those assigned to control/education. Jenny Craig resulted in at least 4.9% greater weight loss at 12 months than control/education and counseling. Nutri-system resulted in at least 3.8% greater weight loss at 3 months than control/education and counseling. Very-low-calorie programs (Health Management Resources, Medifast, and OPTIFAST) resulted in at least 4.0% greater short-term weight loss than counseling, but some attenuation of effect occurred beyond 6 months when reported. Atkins resulted in 0.1% to 2.9% greater weight loss at 12 months than counseling. Results for SlimFast were mixed. We found limited evidence to evaluate adherence or harms for all programs and weight outcomes for other commercial programs. Limitation: Many trials were short (<12 months), had high attrition, and lacked blinding. Conclusion: Clinicians could consider referring overweight or obese patients to Weight Watchers or Jenny Craig. Other popular programs, such as Nutrisystem, show promising weight-loss results; however, additional studies evaluating long-term outcomes are needed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据